Radium-223 plus abiraterone in metastatic castration-resistant prostate cancer: a cautionary tale

被引：7
|
作者：
Sedhom, Ramy [1 ]
Antonarakis, Emmanuel S. [1 ]
机构：
[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD USA
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2019年 / 8卷
基金：
美国国家卫生研究院;
关键词：
BONE METASTASIS; SURVIVAL; ENZALUTAMIDE; ACETATE;
D O I：
10.21037/tau.2019.05.02
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：S341 / S345
页数：5
相关论文
共 50 条
  • [31] Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
    Michel L. Peters
    Claudine de Meijer
    Dirk Wyndaele
    Walter Noordzij
    Annemarie M. Leliveld-Kors
    Joan van den Bosch
    Pieter H. van den Berg
    Agni Baka
    Jennifer G. Gaultney
    Applied Health Economics and Health Policy, 2018, 16 : 145 - 145
  • [32] Selection and monitoring of patients with metastatic castration-resistant prostate cancer for treatment with radium-223
    A. Rodriguez-Vida
    M. D. Torregrosa
    Á. Pinto
    M. Á. Climent
    D. Olmos
    J. Carles
    Clinical and Translational Oncology, 2018, 20 : 679 - 686
  • [33] When to Initiate Treatment With Radium-223 in Patients With Metastatic Castration-Resistant Prostate Cancer
    Shore, Neal D.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (01) : 26 - 29
  • [34] RADIUM 223 FOR THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Miranda, Jesus
    Vinal, David
    Pinto, Alvaro
    ARCHIVOS ESPANOLES DE UROLOGIA, 2019, 72 (05): : 500 - 507
  • [35] eRADicAte: A Prospective Evaluation Combining Radium-223 Dichloride and Abiraterone Acetate Plus Prednisone in Patients With Castration-Resistant Prostate Cancer
    Shore, Neal D.
    Tutrone, Ronald F.
    Mariados, Neil F.
    Nordquist, Luke T.
    Mehlhaff, Bryan A.
    Steere, Karyn J.
    Harrelson, Stacey S.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : 149 - 154
  • [36] Combination Therapy With Radium-223 and Enzalutamide in Castration-Resistant Prostate Cancer
    Maughan, Benjamin L.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (12) : 764 - 766
  • [37] Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223
    Caffo, Orazio
    Frantellizzi, Viviana
    Tucci, Marcello
    Galli, Luca
    Monari, Fabio
    Baldari, Sergio
    Masini, Cristina
    Bortolus, Roberto
    Facchini, Gaetano
    Alongi, Pierpaolo
    Agostini, Stefania
    Zichi, Clizia
    Biasco, Elisa
    Fanti, Stefano
    Pignata, Salvatore
    Filice, Angelina
    Borsatti, Eugenio
    Rossetti, Sabrina
    Spada, Massimiliano
    Cortesi, Enrico
    De Vincentis, Giuseppe
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (11) : 2633 - 2638
  • [38] Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223
    Orazio Caffo
    Viviana Frantellizzi
    Marcello Tucci
    Luca Galli
    Fabio Monari
    Sergio Baldari
    Cristina Masini
    Roberto Bortolus
    Gaetano Facchini
    Pierpaolo Alongi
    Stefania Agostini
    Clizia Zichi
    Elisa Biasco
    Stefano Fanti
    Salvatore Pignata
    Angelina Filice
    Eugenio Borsatti
    Sabrina Rossetti
    Massimiliano Spada
    Enrico Cortesi
    Giuseppe De Vincentis
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 2633 - 2638
  • [39] Evolving treatment approaches for the management of metastatic castration-resistant prostate cancer - role of radium-223
    Mukherji, Deborah
    El Dika, Imane
    Temraz, Sally
    Haidar, Mohammed
    Shamseddine, Ali
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 373 - 380
  • [40] Radium-223 Dichloride in Peritoneal Dialysate Following Treatment of Metastatic Castration-resistant Prostate Cancer
    Saganich, Christopher
    Zgaljardic, Michael
    HEALTH PHYSICS, 2022, 122 (03): : 433 - 439
12345